ArticleJournal of hepatocellular carcinoma2022

Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma.

Jin-Xing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.